Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors

Despite the emerging threat of the Mayaro virus (MAYV) in Central and South-America, there are no licensed antivirals or vaccines available for this neglected mosquito-borne virus. Here, we optimized a robust antiviral assay based on the inhibition of the cytopathogenic effect that could be used for...

Descripción completa

Detalles Bibliográficos
Autores principales: Langendries, Lana, Abdelnabi, Rana, Neyts, Johan, Delang, Leen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065421/
https://www.ncbi.nlm.nih.gov/pubmed/33807492
http://dx.doi.org/10.3390/microorganisms9040734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065421/
https://www.ncbi.nlm.nih.gov/pubmed/33807492
http://dx.doi.org/10.3390/microorganisms9040734

Ejemplares similares